Cedars-Sinai Announces Addition of New Researchers, Physicians to Faculty
By The ASCO Post Staff
October 10, 2020
In a news release issued earlier this month, Dan Theodorescu, MD, PhD, Director of Cedars-Sinai Cancer Center in Los Angeles, welcomed several new researchers and physicians to the faculty of the institution. “I am very grateful to the institutional leadership that our efforts to expand the breadth and depth of Cedars-Sinai Cancer faculty have continued unabated, despite the current challenges posed by the COVID-19 pandemic,” said Dr. Theodorescu, “These exceptional clinicians and scientists will continue to build on our foundation as a leading cancer research and clinical center.”
Physicians and researchers joining Cedars-Sinai Cancer’s Division of Medical Oncology:
- Alexander Boiko, PhD: Dr. Boiko’s research focuses on the cellular and molecular origins of human melanoma. He comes from the University of California, Irvine. Dr. Boiko will work with the translational melanoma team at Cedars-Sinai Cancer at The Angeles Clinic and Research Institute.
- Leigh Ellis, PhD: Dr. Ellis’ work explores the underlying genetic and epigenetic mechanisms concerning the progression of castrate-resistant prostate cancer. He also specializes in oncologic pathology and molecular and cellular biology. He currently serves as Assistant Professor in Pathology at Harvard Medical School.
- Sergei Grivennikov, PhD: Dr. Grivennikov’s research examines the connection of various immune signaling pathways with the pathogenesis of inflammation-associated and sporadic cancers. He comes from the Fox Chase Cancer Center in Philadelphia, where he currently is an Associate Professor in the Cancer Prevention and Control Program.
- Ekaterina Koltsova, PhD: Dr. Koltsova’s research studies the role of cytokines in the regulation of intestinal microbiota and inflammation in cancer and cardiovascular disease. She currently is an Associate Professor in the Blood Cell Development and Function Program at the Fox Chase Cancer Center in Philadelphia. She will join both Cedars-Sinai Cancer at the Samuel Oschin Comprehensive Cancer Institute and the Department of Cardiology.
- Xue Sean Li, PhD: Dr. Li’s research investigates gender disparities in bladder cancer as well as benign urologic diseases, such as urinary tract infection, and bladder urothelial regeneration. He currently is an Associate Professor of Surgery at the Boston Children’s Hospital at Harvard Medical School.
- Arsen Osipov, MD: Dr. Osipov will provide clinical care to gastrointestinal oncology patients and will focus his research efforts on translational pancreatic cancer studies to help advance progress in prevention and treatment. Dr. Osipov previously served as a Chief Medical Oncology Fellow and Clinical Translational Investigator at the Johns Hopkins Cancer Center.